TechNavio's analysts forecast the Global Protein Therapeutics market to grow at a CAGR of 7.08 percent over the period 2012–2016. One of the key factors contributing to this market growth is the increasing prevalence of chronic diseases. The market has also been witnessing increasing outsourcing of drug development. However, patent-expiration of top-selling drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Protein Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global Protein Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Roche Holding Ltd., Amgen Inc., Abbott Laboratories, J&J, and Novo Nordisk A/S.
The other vendors mentioned in this report are AstraZeneca plc, Biogen Idec Inc., Eli Lilly and Co., Novartis International AG, Bristol Myers Squibb Co., Merck & Co. Inc., Pfizer Inc., Curis Inc., UCB S.A., Elan Corporations Plc, Human Genome Sciences Inc., Daiichi Sankyo Co. Ltd., and GlaxoSmithKline plc.
Key questions answered in this report:
What will the market size be in 2015 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Market Size and Forecast
Market Segmentation
06.2 Global Monoclonal Antibodies market
Market Size and Forecast
Market Segmentation
Top Monoclonal Antibodies Drugs
06.3 Global Insulin Market
Market Segmentation
Top Insulin Drugs
06.4 Global Erythropoietin Market
Market Size and Forecast
06.5 Five Forces Analysis
07. Geographical Segmentation
08. Vendor Landscape
08.1 Global Protein Therapeutics Market
08.2 Global Monoclonal Antibodies Market
08.3 Global Insulin Market
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Abbott Laboratories
Business Overview
Key Information
SWOT Analysis
15.2 Amgen Inc.
Business Overview
Key Information
SWOT Analysis
15.3 Roche Holding Ltd.
Business Overview
Key Information
SWOT Analysis
15.4 Johnson & Johnson
Business Overview
Key Information
SWOT Analysis
15.5 Novo Nordisk A/S
Business Overview
Key Information
SWOT Analysis
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Protein Therapeutics Market 2012-2016 (US$ billion)
Exhibit 3: Global Protein Therapeutics Market Segmentation
Exhibit 4: Global Protein Therapeutics Market Segmentation 2012
Exhibit 5: Global Monoclonal Antibodies Market 2012–2016 (US$ billion)
Exhibit 6: Global Monoclonal Antibodies Market Segmentation Based on Application
Exhibit 7: Global Monoclonal Antibodies Market Segmentation 2011
Exhibit 8: Top Drugs in the Global Monoclonal Antibodies Market 2012(US$ billion)
Exhibit 9: Top Drugs in Global Monoclonal Antibodies Market 2012 (percentage)
Exhibit 10: Global Insulin Market 2012–2016 (US$ billion)
Exhibit 11: Global Insulin Market Segmentation
Exhibit 12: Global Insulin Market Segmentation 2012
Exhibit 13: Top Drugs in the Global Monoclonal Antibodies Market 2012(US$ billion)
Exhibit 14: Top Drugs in Global Monoclonal Antibodies Market 2012 (percentage)
Exhibit 15: Global Erythropoietin Market 2012–2016 (US$ billion)
Exhibit 16: Global Protein Therapeutics Market by Geographical Segmentation 2012
Exhibit 17: Global Protein Therapeutics Market by Vendor Segmentation 2012
Exhibit 18: Global Monoclonal Antibodies Market by Vendor Segmentation 2012
Exhibit 19: Global Insulin Market by Vendor Segmentation 2012
Exhibit 20: Business Segmentation of Abbott Laboratories
Exhibit 21: Business Segmentation of Roche Holding Ltd.
Exhibit 22: Business Segmentation of Johnson & Johnson
Exhibit 23: Business Segmentation of Novo Nordisk A/S